Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 453

1.

18F-FDG PET/CT Radiomic Analysis with Machine Learning for Identifying Bone Marrow Involvement in the Patients with Suspected Relapsed Acute Leukemia.

Li H, Xu C, Xin B, Zheng C, Zhao Y, Hao K, Wang Q, Wahl RL, Wang X, Zhou Y.

Theranostics. 2019 Jul 9;9(16):4730-4739. doi: 10.7150/thno.33841. eCollection 2019.

2.

Reply to E. Hindié et al.

Connolly RM, Huang CY, Stearns V, Wahl RL.

J Clin Oncol. 2019 Aug 10;37(23):2092-2093. doi: 10.1200/JCO.19.01078. Epub 2019 Jun 28. No abstract available.

PMID:
31251693
3.

Repeatability of Quantitative Brown Adipose Tissue Imaging Metrics on Positron Emission Tomography with 18F-Fluorodeoxyglucose in Humans.

Fraum TJ, Crandall JP, Ludwig DR, Chen S, Fowler KJ, Laforest RA, Salter A, Dehdashti F, An H, Wahl RL.

Cell Metab. 2019 Jul 2;30(1):212-224.e4. doi: 10.1016/j.cmet.2019.05.019. Epub 2019 Jun 20.

PMID:
31230985
4.

Repeatability of brown adipose tissue measurements on FDG PET/CT following a simple cooling procedure for BAT activation.

Crandall JP, Gajwani P, O JH, Mawhinney DD, Sterzer F, Wahl RL.

PLoS One. 2019 Apr 17;14(4):e0214765. doi: 10.1371/journal.pone.0214765. eCollection 2019.

5.

Measurement Repeatability of 18F-FDG PET/CT Versus 18F-FDG PET/MRI in Solid Tumors of the Pelvis.

Fraum TJ, Fowler KJ, Crandall JP, Laforest RA, Salter A, An H, Jacobs MA, Grigsby PW, Dehdashti F, Wahl RL.

J Nucl Med. 2019 Aug;60(8):1080-1086. doi: 10.2967/jnumed.118.218735. Epub 2019 Feb 7.

6.

TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathologic Complete Response to Pertuzumab and Trastuzumab in Breast Cancer.

Connolly RM, Leal JP, Solnes L, Huang CY, Carpenter A, Gaffney K, Abramson V, Carey LA, Liu MC, Rimawi M, Specht J, Storniolo AM, Valero V, Vaklavas C, Krop IE, Winer EP, Camp M, Miller RS, Wolff AC, Cimino-Mathews A, Park BH, Wahl RL, Stearns V.

J Clin Oncol. 2019 Mar 20;37(9):714-722. doi: 10.1200/JCO.2018.78.7986. Epub 2019 Feb 5.

PMID:
30721110
7.

Reply: Radiation Dose Does Matter: Mechanistic Insights into DNA Damage and Repair Support the Linear No-Threshold Model of Low-Dose Radiation Health Risks.

Duncan JR, Lieber MR, Adachi N, Wahl RL.

J Nucl Med. 2019 Mar;60(3):437-438. doi: 10.2967/jnumed.118.223461. Epub 2019 Jan 10. No abstract available.

PMID:
30630943
8.

Discussions with Leaders: A Conversation Between Richard Wahl and Johannes Czernin.

Wahl RL, Czernin J.

J Nucl Med. 2019 Jan;60(1):3-6. doi: 10.2967/jnumed.118.223503. No abstract available.

PMID:
30602594
9.

SNMMI Leadership Update: New Initiatives in Research and Discovery.

Wahl RL.

J Nucl Med. 2018 Dec;59(12):22N. No abstract available.

PMID:
30510078
10.

Dynamic whole-body PET imaging: principles, potentials and applications.

Rahmim A, Lodge MA, Karakatsanis NA, Panin VY, Zhou Y, McMillan A, Cho S, Zaidi H, Casey ME, Wahl RL.

Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):501-518. doi: 10.1007/s00259-018-4153-6. Epub 2018 Sep 29. Review.

PMID:
30269154
11.

Reply: Radiation Dose Does Matter: Mechanistic Insights into DNA Damage and Repair Support the Linear No-Threshold Model of Low-Dose Radiation Health Risks

Duncan JR, Lieber MR, Adachi N, Wahl RL.

J Nucl Med. 2018 Nov;59(11):1780-1781. doi: 10.2967/jnumed.118.218321. Epub 2018 Sep 27. No abstract available.

PMID:
30262519
12.

The Use of Quantitative Imaging in Radiation Oncology: A Quantitative Imaging Network (QIN) Perspective.

Press RH, Shu HG, Shim H, Mountz JM, Kurland BF, Wahl RL, Jones EF, Hylton NM, Gerstner ER, Nordstrom RJ, Henderson L, Kurdziel KA, Vikram B, Jacobs MA, Holdhoff M, Taylor E, Jaffray DA, Schwartz LH, Mankoff DA, Kinahan PE, Linden HM, Lambin P, Dilling TJ, Rubin DL, Hadjiiski L, Buatti JM.

Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1219-1235. doi: 10.1016/j.ijrobp.2018.06.023. Epub 2018 Jun 30. Review.

13.

Spatial relationship of 2-deoxy-2-[18F]-fluoro-D-glucose positron emission tomography and magnetic resonance diffusion imaging metrics in cervical cancer.

Floberg JM, Fowler KJ, Fuser D, DeWees TA, Dehdashti F, Siegel BA, Wahl RL, Schwarz JK, Grigsby PW.

EJNMMI Res. 2018 Jun 15;8(1):52. doi: 10.1186/s13550-018-0403-7.

14.

Radiation Dose Does Matter: Mechanistic Insights into DNA Damage and Repair Support the Linear No-Threshold Model of Low-Dose Radiation Health Risks.

Duncan JR, Lieber MR, Adachi N, Wahl RL.

J Nucl Med. 2018 Jul;59(7):1014-1016. doi: 10.2967/jnumed.118.210252. Epub 2018 May 31. No abstract available.

15.

Multiparametric Whole-body MRI with Diffusion-weighted Imaging and ADC Mapping for the Identification of Visceral and Osseous Metastases From Solid Tumors.

Jacobs MA, Macura KJ, Zaheer A, Antonarakis ES, Stearns V, Wolff AC, Feiweier T, Kamel IR, Wahl RL, Pan L.

Acad Radiol. 2018 Nov;25(11):1405-1414. doi: 10.1016/j.acra.2018.02.010. Epub 2018 Apr 4.

16.

Measurement of Brown Adipose Tissue Activity Using Microwave Radiometry and 18F-FDG PET/CT.

Crandall JP, O JH, Gajwani P, Leal JP, Mawhinney DD, Sterzer F, Wahl RL.

J Nucl Med. 2018 Aug;59(8):1243-1248. doi: 10.2967/jnumed.117.204339. Epub 2018 Feb 9.

17.

Feasibility Evaluation of Myocardial Cannabinoid Type 1 Receptor Imaging in Obesity: A Translational Approach.

Valenta I, Varga ZV, Valentine H, Cinar R, Horti A, Mathews WB, Dannals RF, Steele K, Kunos G, Wahl RL, Pomper MG, Wong DF, Pacher P, Schindler TH.

JACC Cardiovasc Imaging. 2018 Feb;11(2 Pt 2):320-332. doi: 10.1016/j.jcmg.2017.11.019.

18.

PERCIST in Perspective.

O JH, Wahl RL.

Nucl Med Mol Imaging. 2018 Feb;52(1):1-4. doi: 10.1007/s13139-017-0507-4. Epub 2017 Dec 18.

19.

Evaluation of Next-Generation Anti-CD20 Antibodies Labeled with 89Zr in Human Lymphoma Xenografts.

Yoon JT, Longtine MS, Marquez-Nostra BV, Wahl RL.

J Nucl Med. 2018 Aug;59(8):1219-1224. doi: 10.2967/jnumed.117.203299. Epub 2018 Jan 18.

20.

Quantitative PET/CT in clinical practice: assessing the agreement of PET tumor indices using different clinical reading platforms.

Mhlanga JC, Chirindel A, Lodge MA, Wahl RL, Subramaniam RM.

Nucl Med Commun. 2018 Feb;39(2):154-160. doi: 10.1097/MNM.0000000000000786.

PMID:
29227348
21.

Non-invasive methods for the assessment of brown adipose tissue in humans.

Chondronikola M, Beeman SC, Wahl RL.

J Physiol. 2018 Feb 1;596(3):363-378. doi: 10.1113/JP274255. Epub 2018 Jan 15. Review.

22.

DNA Repair After Exposure to Ionizing Radiation Is Not Error-Free.

Duncan JR, Lieber MR, Adachi N, Wahl RL.

J Nucl Med. 2018 Feb;59(2):348. doi: 10.2967/jnumed.117.197673. Epub 2017 Aug 3. No abstract available.

23.

Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas.

Holdhoff M, Ye X, Supko JG, Nabors LB, Desai AS, Walbert T, Lesser GJ, Read WL, Lieberman FS, Lodge MA, Leal J, Fisher JD, Desideri S, Grossman SA, Wahl RL, Schiff D.

Neuro Oncol. 2017 Jun 1;19(6):845-852. doi: 10.1093/neuonc/nox020.

24.

Quantitation of Cancer Treatment Response by 18F-FDG PET/CT: Multicenter Assessment of Measurement Variability.

O JH, Jacene H, Luber B, Wang H, Huynh MH, Leal JP, Wahl RL.

J Nucl Med. 2017 Sep;58(9):1429-1434. doi: 10.2967/jnumed.117.189605. Epub 2017 Mar 30.

25.

Prediction of Response to Immune Checkpoint Inhibitor Therapy Using Early-Time-Point 18F-FDG PET/CT Imaging in Patients with Advanced Melanoma.

Cho SY, Lipson EJ, Im HJ, Rowe SP, Gonzalez EM, Blackford A, Chirindel A, Pardoll DM, Topalian SL, Wahl RL.

J Nucl Med. 2017 Sep;58(9):1421-1428. doi: 10.2967/jnumed.116.188839. Epub 2017 Mar 30.

26.

The effect of regadenoson on the integrity of the human blood-brain barrier, a pilot study.

Jackson S, George RT, Lodge MA, Piotrowski A, Wahl RL, Gujar SK, Grossman SA.

J Neurooncol. 2017 May;132(3):513-519. doi: 10.1007/s11060-017-2404-1. Epub 2017 Mar 17.

27.

Simplifying volumes-of-interest (VOIs) definition in quantitative SPECT: Beyond manual definition of 3D whole-organ VOIs.

Vicente EM, Lodge MA, Rowe SP, Wahl RL, Frey EC.

Med Phys. 2017 May;44(5):1707-1717. doi: 10.1002/mp.12164. Epub 2017 Mar 28.

28.

A comparison of FLT to FDG PET/CT in the early assessment of chemotherapy response in stages IB-IIIA resectable NSCLC.

Crandall JP, Tahari AK, Juergens RA, Brahmer JR, Rudin CM, Esposito G, Subramaniam DS, Knopp MV, Hall NC, Gajwani P, Leal JP, Lodge MA, O JH, Gabrielson EW, Shankar LK, Wahl RL.

EJNMMI Res. 2017 Dec;7(1):8. doi: 10.1186/s13550-017-0258-3. Epub 2017 Jan 19.

29.

Spatiotemporal distribution modeling of PET tracer uptake in solid tumors.

Soltani M, Sefidgar M, Bazmara H, Casey ME, Subramaniam RM, Wahl RL, Rahmim A.

Ann Nucl Med. 2017 Feb;31(2):109-124. doi: 10.1007/s12149-016-1141-4. Epub 2016 Dec 5.

PMID:
27921285
30.

Initial Experience with Tositumomab and I-131-Labeled Tositumomab for Treatment of Relapsed/Refractory Hodgkin Lymphoma.

Jacene H, Crandall J, Kasamon YL, Ambinder RF, Piantadosi S, Serena D, Kasecamp W, Wahl RL.

Mol Imaging Biol. 2017 Jun;19(3):429-436. doi: 10.1007/s11307-016-1019-9.

PMID:
27798787
31.

Comparison of quantitative Y-90 SPECT and non-time-of-flight PET imaging in post-therapy radioembolization of liver cancer.

Yue J, Mauxion T, Reyes DK, Lodge MA, Hobbs RF, Rong X, Dong Y, Herman JM, Wahl RL, Geschwind JH, Frey EC.

Med Phys. 2016 Oct;43(10):5779.

32.

Repeatability of 18F-FLT PET in a Multicenter Study of Patients with High-Grade Glioma.

Lodge MA, Holdhoff M, Leal JP, Bag AK, Nabors LB, Mintz A, Lesser GJ, Mankoff DA, Desai AS, Mountz JM, Lieberman FS, Fisher JD, Desideri S, Ye X, Grossman SA, Schiff D, Wahl RL.

J Nucl Med. 2017 Mar;58(3):393-398. doi: 10.2967/jnumed.116.178434. Epub 2016 Sep 29.

33.

Assessment of Imaging Modalities and Response Metrics in Ewing Sarcoma: Correlation With Survival.

Koshkin VS, Bolejack V, Schwartz LH, Wahl RL, Chugh R, Reinke DK, Zhao B, O JH, Patel SR, Schuetze SM, Baker LH.

J Clin Oncol. 2016 Oct 20;34(30):3680-3685. doi: 10.1200/JCO.2016.68.1858.

34.

Brown Adipose Reporting Criteria in Imaging STudies (BARCIST 1.0): Recommendations for Standardized FDG-PET/CT Experiments in Humans.

Chen KY, Cypess AM, Laughlin MR, Haft CR, Hu HH, Bredella MA, Enerbäck S, Kinahan PE, Lichtenbelt Wv, Lin FI, Sunderland JJ, Virtanen KA, Wahl RL.

Cell Metab. 2016 Aug 9;24(2):210-22. doi: 10.1016/j.cmet.2016.07.014. Review.

35.

Posttreatment FDG PET/CT in predicting survival of patients with ovarian carcinoma.

Chu LC, Tsai HL, Wang H, Crandall J, Javadi MS, Wahl RL.

EJNMMI Res. 2016 Dec;6(1):42. doi: 10.1186/s13550-016-0194-7. Epub 2016 May 20.

36.

Practical PERCIST: A Simplified Guide to PET Response Criteria in Solid Tumors 1.0.

O JH, Lodge MA, Wahl RL.

Radiology. 2016 Aug;280(2):576-84. doi: 10.1148/radiol.2016142043. Epub 2016 Feb 24. Review.

37.

Quo Vadis: PET and Single-Photon Molecular Breast Imaging.

Wahl RL.

J Nucl Med. 2016 Feb;57 Suppl 1:3S-8S. doi: 10.2967/jnumed.115.159202. Review. No abstract available.

38.

Response to Early Treatment Evaluated with 18F-FDG PET and PERCIST 1.0 Predicts Survival in Patients with Ewing Sarcoma Family of Tumors Treated with a Monoclonal Antibody to the Insulinlike Growth Factor 1 Receptor.

Hyun O J, Luber BS, Leal JP, Wang H, Bolejack V, Schuetze SM, Schwartz LH, Helman LJ, Reinke D, Baker LH, Wahl RL.

J Nucl Med. 2016 May;57(5):735-40. doi: 10.2967/jnumed.115.162412. Epub 2016 Jan 21.

39.

Quantitative Imaging in Cancer Clinical Trials.

Yankeelov TE, Mankoff DA, Schwartz LH, Lieberman FS, Buatti JM, Mountz JM, Erickson BJ, Fennessy FM, Huang W, Kalpathy-Cramer J, Wahl RL, Linden HM, Kinahan PE, Zhao B, Hylton NM, Gillies RJ, Clarke L, Nordstrom R, Rubin DL.

Clin Cancer Res. 2016 Jan 15;22(2):284-90. doi: 10.1158/1078-0432.CCR-14-3336. Review.

40.

Racial Disparities in Asthma Hospitalizations Following Implementation of the Smoke-Free Air Law, Michigan, 2002-2012.

Marchese ME, Shamo F, Miller CE, Wahl RL, Li Y.

Prev Chronic Dis. 2015 Nov 19;12:E201. doi: 10.5888/pcd12.150144.

41.

Strengths and Weaknesses of a Planar Whole-Body Method of (153)Sm Dosimetry for Patients with Metastatic Osteosarcoma and Comparison with Three-Dimensional Dosimetry.

Plyku D, Loeb DM, Prideaux AR, Baechler S, Wahl RL, Sgouros G, Hobbs RF.

Cancer Biother Radiopharm. 2015 Nov;30(9):369-79. doi: 10.1089/cbr.2014.1803.

42.

Generalized whole-body Patlak parametric imaging for enhanced quantification in clinical PET.

Karakatsanis NA, Zhou Y, Lodge MA, Casey ME, Wahl RL, Zaidi H, Rahmim A.

Phys Med Biol. 2015 Nov 21;60(22):8643-73. doi: 10.1088/0031-9155/60/22/8643. Epub 2015 Oct 28.

44.

Optimal definition of biological tumor volume using positron emission tomography in an animal model.

Wu I, Wang H, Huso D, Wahl RL.

EJNMMI Res. 2015 Dec;5(1):58. doi: 10.1186/s13550-015-0134-y. Epub 2015 Oct 21.

45.

Hyaluronic acid-serum hydrogels rapidly restore metabolism of encapsulated stem cells and promote engraftment.

Chan AT, Karakas MF, Vakrou S, Afzal J, Rittenbach A, Lin X, Wahl RL, Pomper MG, Steenbergen CJ, Tsui BM, Elisseeff JH, Abraham MR.

Biomaterials. 2015 Dec;73:1-11. doi: 10.1016/j.biomaterials.2015.09.001. Epub 2015 Sep 4.

46.

Observational Retrospective Study of Altered Biodistribution of Tositumomab and 131I-Tositumomab.

Wahl RL, Horner TJ, Lin TS, Kaminski MS.

J Nucl Med. 2015 Nov;56(11):1800-3. doi: 10.2967/jnumed.115.156190. Epub 2015 Sep 3.

47.

Metrology Standards for Quantitative Imaging Biomarkers.

Sullivan DC, Obuchowski NA, Kessler LG, Raunig DL, Gatsonis C, Huang EP, Kondratovich M, McShane LM, Reeves AP, Barboriak DP, Guimaraes AR, Wahl RL; RSNA-QIBA Metrology Working Group.

Radiology. 2015 Dec;277(3):813-25. doi: 10.1148/radiol.2015142202. Epub 2015 Aug 12.

48.

Factors affecting the stability and repeatability of gamma camera calibration for quantitative imaging applications based on a retrospective review of clinical data.

Anizan N, Wang H, Zhou XC, Hobbs RF, Wahl RL, Frey EC.

EJNMMI Res. 2014 Dec;4(1):67. doi: 10.1186/s13550-014-0067-x. Epub 2014 Dec 16.

49.

Late gadolinium enhancement confined to the right ventricular insertion points in hypertrophic cardiomyopathy: an intermediate stage phenotype?

Bravo PE, Luo HC, Pozios I, Zimmerman SL, Corona-Villalobos CP, Sorensen L, Kamel IR, Bluemke DA, Wahl RL, Abraham MR, Abraham TP.

Eur Heart J Cardiovasc Imaging. 2016 Mar;17(3):293-300. doi: 10.1093/ehjci/jev154. Epub 2015 Jun 14.

50.

Performance assessment of a NaI(Tl) gamma counter for PET applications with methods for improved quantitative accuracy and greater standardization.

Lodge MA, Holt DP, Kinahan PE, Wong DF, Wahl RL.

EJNMMI Phys. 2015 May;2. pii: 11. doi: 10.1186/s40658-015-0114-3.

Supplemental Content

Support Center